Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naive and malaria-exposed individuals

被引:22
作者
Bejon, Philip
Keating, Sheila
Mwacharo, Jedidah
Kai, Oscar K.
Dunachie, Susanna
Walther, Michael
Berthoud, Tamara
Lang, Trudie
Epstein, Judy
Carucci, Daniel
Moris, Philippe
Cohen, Joe
Gilbert, Sarah C.
Peshu, Norbert
Marsh, Kevin
Hill, Adrian V. S.
机构
[1] Ctr Geog Med Res, Kenya Med Res Inst, Kilifi, Kenya
[2] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England
[3] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England
[4] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford, England
[5] GlaxoSmithKline Biol, Rixensart, Belgium
[6] USN, Med Res Ctr, Silver Spring, MD 20903 USA
基金
英国医学研究理事会; 英国惠康基金;
关键词
D O I
10.1128/IAI.00774-06
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Two different cell populations respond to potent T-cell-inducing vaccinations. The induction and loss of effector cells can be seen using an ex vivo enzyme-linked immunospot (ELISPOT) assay, but the more durable resting memory response is demonstrable by a cultured ELISPOT assay. The relationship of the early effector response to durable resting memory is incompletely understood. Effector phenotype is usually identified by gamma interferon (IFN-gamma) production, but interleukin-2 (IL-2) has been specifically linked to the differentiation of memory cells. Here, WN-gamma- and IL-2-secreting effector cells were identified by an ex vivo ELISPOT assay 1 week after vaccination and compared with the resting memory responses detected by a cultured ELISPOT assay 3 months later. The different kinetics and induction of IL-2 by different vaccines and natural exposure are described. Furthermore, both early IFN-gamma and IL-2 production independently predicted subsequent memory responses at 3 months in malaria-naive volunteers, but only IFN-gamma predicted memory in malaria-exposed volunteers. However, dual ELISPOT assays were also performed on malaria-exposed volunteers to identify cells producing both cytokines simultaneously. This demonstrated that double-cytokine-producing cells were highly predictive of memory. This assay may be useful in predicting vaccinations most likely to generate stable, long-term memory responses.
引用
收藏
页码:6331 / 6338
页数:8
相关论文
共 33 条
[1]   CD4 cell response to 3 doses of subcutaneous interleukin 2: Meta-analysis of 3 Vanguard studies [J].
Arduino, RC ;
Nannini, EC ;
Rodriguez-Barradas, M ;
Schrader, S ;
Losso, M ;
Ruxrungtham, K ;
Allende, MC ;
Emery, S ;
Fosdick, L ;
Neaton, J ;
Tavel, JA ;
Davey, RT ;
Lane, HC .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) :115-122
[2]   Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area [J].
Bejon, Philip ;
Kai, Oscar K. ;
Mwacharo, Jedidah ;
Keating, Sheila ;
Lang, Trudie ;
Gilbert, Sarah C. ;
Peshu, Norbert ;
Marsh, Kevin ;
Hill, Adrian V. S. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (08) :2264-2272
[3]   Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo [J].
Blattman, JN ;
Grayson, JM ;
Wherry, EJ ;
Kaech, SM ;
Smith, KA ;
Ahmed, R .
NATURE MEDICINE, 2003, 9 (05) :540-547
[4]   Presence of HIV-1 gag-specific IFN-γ+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection [J].
Boaz, MJ ;
Waters, A ;
Murad, S ;
Easterbrook, PJ ;
Vyakarnam, A .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6376-6385
[5]   Expansion of activated human naive T-cells precedes effector function [J].
Brenchley, JM ;
Douek, DC ;
Ambrozak, DR ;
Chatterji, M ;
Betts, MR ;
Davis, LS ;
Koup, RA .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (03) :431-440
[6]   Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death [J].
Cheng, LE ;
Öhlén, C ;
Nelson, BH ;
Greenberg, PD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) :3001-3006
[7]   The complexity of protective immunity against liver-stage malaria [J].
Doolan, DL ;
Hoffman, SL .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1453-1462
[8]   Pre-erythrocytic-stage immune effector mechanisms in Plasmodium spp. infections [J].
Doolan, DL ;
Hoffman, SL .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1997, 352 (1359) :1361-1367
[9]   A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS [J].
Dunachie, SJ ;
Walther, M ;
Vuola, JM ;
Webster, DP ;
Keating, SM ;
Berthoud, T ;
Andrews, L ;
Bejon, P ;
Poulton, I ;
Butcher, G ;
Watkins, K ;
Sinden, RE ;
Leach, A ;
Moris, P ;
Tornieporth, N ;
Schneider, J ;
Dubovsky, F ;
Tierney, E ;
Williams, J ;
Heppner, DG ;
Gilbert, SC ;
Cohen, J ;
Hill, AVS .
VACCINE, 2006, 24 (15) :2850-2859
[10]   Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A [J].
Epstein, JE ;
Charoenvit, Y ;
Kester, KE ;
Wang, RB ;
Newcomer, R ;
Fitzpatrick, S ;
Richie, TL ;
Tornieporth, N ;
Heppner, DG ;
Ockenhouse, C ;
Majam, V ;
Holland, C ;
Abot, E ;
Ganeshan, H ;
Berzins, M ;
Jones, T ;
Freydberg, CN ;
Ng, J ;
Norman, J ;
Carucci, DJ ;
Cohen, J ;
Hoffman, SL .
VACCINE, 2004, 22 (13-14) :1592-1603